Injective's DeFi ecosystem is gaining momentum as its Total Value Locked (TVL) climbed 22% in a week, reaching $31 million.

This milestone marks a key development for the project, putting it ahead of peers like Abstract, Swellchain, and Metis in TVL rankings.

Injective, a blockchain known for its DeFi ecosystem, has seen substantial Total Value Locked (TVL) growth, adding 22% to reach $31 million. This achievement places the project ahead of several competitors, notably Abstract, Swellchain, and Metis, in TVL rankings.

The continuous rise in TVL over the past week also saw a triple-digit gain observed as early as May 2025, showcasing sustained institutional interest and user engagement, even amid broader market cooling.

Moreover, activity around Injective has been strengthening as DeFi protocols are shifting toward sustainability and real-world use cases, a factor that saw ATOM, a blockchain known for its sustainability efforts, recently cross the $30 billion TVL milestone.

The market’s recent behavior is showing a maturing phase, with utility now driving capital flows more visibly than in previous cycles.

As crypto liquidity continues to deepen across platforms, showcasing a structural shift in 2025, Injective’s multi-chain compatibility and performance-driven tools appear to be attracting investor attention.

Its recent TVL numbers also reflect stronger fundamentals compared to its direct competitors, evident in the sustained rise of its native token, INJ.

INJ Price Declines Despite Earlier Gains

INJ, Injective’s native token, is currently trading at $13.19, showing a weekly gain of 7.59%, according to CoinGecko. However, over the last 24 hours, the price declined by 5.55%, with the trading range seen between $11.31 and $14.26. Despite the recent dip in daily volume by 14.40%, the token maintains healthy liquidity with over $107 million in transactions in the past day.

Crypto analyst DΞ'Sama H suggests that INJ’s current price range between $12.90 and $14.02 may serve as a stable entry zone for long-term investors.

With around 99 million tokens in circulation and a market cap near $1.3 billion, the asset shows signs of strength in a transitioning DeFi landscape. He suggests that if Injective continues executing on its roadmap, mid-term price targets between $16 and $18 are achievable.

"Gm 🥷,

Here’s the current update on $INJ, along with insights on what long-term investors should expect:

◾️ Price: Around $13.03, trading within the $12.90–$14.02 intraday range

◾️ Market Cap: Roughly $1.30 billion, with ~99 million $INJ in circulation

◾️ Volume & Action: After yesterday’s +14.40% surge, the 24-hr volume stands at $107 million.